Egypt becomes 1st African nation to achieve advanced WHO Drug Oversight Classification

Egypt has become the first African nation to achieve an advanced classification in the oversight of domestically manufactured drugs and vaccines, according to the Egyptian Drug Authority (EDA). The EDA highlighted the significance of this achievement, stating that it reflects Egypt’s commitment to ensuring the availability of safe, effective, and high-quality medical products.

Ali Al-Ghamrawy, head of the EDA, affirmed the authority’s dedication to international standards. “This high-level achievement is a result of Egypt’s commitment to ensuring the availability of safe, effective, and high-quality medical products,” he said.

In a statement, Al-Ghamrawy noted that the EDA has been developing institutional excellence indicators at the international level for the past five years, adhering to the latest global regulatory references. He added that ongoing modernization and development across the EDA’s technical, administrative, technological, and regulatory functions have strengthened its prospects for obtaining numerous high-level international accreditations.

Al-Ghamrawy expressed gratitude to President Abdel Fattah El-Sisi for his support of the pharmaceutical sector. He said that Egypt’s attainment of advanced international accreditations is a direct result of the President’s patronage, directives, and continuous support for the Egyptian pharmaceutical industry.